233 related articles for article (PubMed ID: 20034403)
1. Nitrosamine exposure exacerbates high fat diet-mediated type 2 diabetes mellitus, non-alcoholic steatohepatitis, and neurodegeneration with cognitive impairment.
de la Monte SM; Tong M; Lawton M; Longato L
Mol Neurodegener; 2009 Dec; 4():54. PubMed ID: 20034403
[TBL] [Abstract][Full Text] [Related]
2. Early limited nitrosamine exposures exacerbate high fat diet-mediated type 2 diabetes and neurodegeneration.
Tong M; Longato L; de la Monte SM
BMC Endocr Disord; 2010 Mar; 10():4. PubMed ID: 20302640
[TBL] [Abstract][Full Text] [Related]
3. Nitrosamine exposure causes insulin resistance diseases: relevance to type 2 diabetes mellitus, non-alcoholic steatohepatitis, and Alzheimer's disease.
Tong M; Neusner A; Longato L; Lawton M; Wands JR; de la Monte SM
J Alzheimers Dis; 2009; 17(4):827-44. PubMed ID: 20387270
[TBL] [Abstract][Full Text] [Related]
4. Hepatic ceramide may mediate brain insulin resistance and neurodegeneration in type 2 diabetes and non-alcoholic steatohepatitis.
Lyn-Cook LE; Lawton M; Tong M; Silbermann E; Longato L; Jiao P; Mark P; Wands JR; Xu H; de la Monte SM
J Alzheimers Dis; 2009; 16(4):715-29. PubMed ID: 19387108
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of nitrosamine-mediated neurodegeneration: potential relevance to sporadic Alzheimer's disease.
de la Monte SM; Tong M
J Alzheimers Dis; 2009; 17(4):817-25. PubMed ID: 19542621
[TBL] [Abstract][Full Text] [Related]
6. Epidemilogical trends strongly suggest exposures as etiologic agents in the pathogenesis of sporadic Alzheimer's disease, diabetes mellitus, and non-alcoholic steatohepatitis.
de la Monte SM; Neusner A; Chu J; Lawton M
J Alzheimers Dis; 2009; 17(3):519-29. PubMed ID: 19363256
[TBL] [Abstract][Full Text] [Related]
7. Ceramide-mediated insulin resistance and impairment of cognitive-motor functions.
de la Monte SM; Tong M; Nguyen V; Setshedi M; Longato L; Wands JR
J Alzheimers Dis; 2010; 21(3):967-84. PubMed ID: 20693650
[TBL] [Abstract][Full Text] [Related]
8. Diabetes is a progression factor for hepatic fibrosis in a high fat fed mouse obesity model of non-alcoholic steatohepatitis.
Lo L; McLennan SV; Williams PF; Bonner J; Chowdhury S; McCaughan GW; Gorrell MD; Yue DK; Twigg SM
J Hepatol; 2011 Aug; 55(2):435-44. PubMed ID: 21184785
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of ceramide-mediated neurodegeneration.
Tong M; de la Monte SM
J Alzheimers Dis; 2009; 16(4):705-14. PubMed ID: 19387107
[TBL] [Abstract][Full Text] [Related]
10. C-type natriuretic peptide (CNP) in endothelial cells attenuates hepatic fibrosis and inflammation in non-alcoholic steatohepatitis.
Bae CR; Hino J; Hosoda H; Miyazato M; Kangawa K
Life Sci; 2018 Sep; 209():349-356. PubMed ID: 30114411
[TBL] [Abstract][Full Text] [Related]
11. Potential contributions of the tobacco nicotine-derived nitrosamine ketone (NNK) in the pathogenesis of steatohepatitis in a chronic plus binge rat model of alcoholic liver disease.
Zabala V; Tong M; Yu R; Ramirez T; Yalcin EB; Balbo S; Silbermann E; Deochand C; Nunez K; Hecht S; de la Monte SM
Alcohol Alcohol; 2015 Mar; 50(2):118-31. PubMed ID: 25618784
[TBL] [Abstract][Full Text] [Related]
12. Biochemical and histological characterisation of an experimental rodent model of non-alcoholic steatohepatitis - Effects of a peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist and a glucagon-like peptide-1 analogue.
Daniels SJ; Leeming DJ; Detlefsen S; Bruun MF; Hjuler ST; Henriksen K; Hein P; Karsdal MA; Brockbank S; Cruwys S
Biomed Pharmacother; 2019 Mar; 111():926-933. PubMed ID: 30841472
[TBL] [Abstract][Full Text] [Related]
13. A high-fat diet reverses improvement in glucose tolerance induced by duodenal-jejunal bypass in type 2 diabetic rats.
Liu SZ; Sun D; Zhang GY; Wang L; Liu T; Sun Y; Li MX; Hu SY
Chin Med J (Engl); 2012 Mar; 125(5):912-9. PubMed ID: 22490596
[TBL] [Abstract][Full Text] [Related]
14. Brain metabolic dysfunction at the core of Alzheimer's disease.
de la Monte SM; Tong M
Biochem Pharmacol; 2014 Apr; 88(4):548-59. PubMed ID: 24380887
[TBL] [Abstract][Full Text] [Related]
15. Role of physical exercise on hepatic insulin, glucocorticoid and inflammatory signaling pathways in an animal model of non-alcoholic steatohepatitis.
Passos E; Pereira CD; Gonçalves IO; Rocha-Rodrigues S; Silva N; Guimarães JT; Neves D; Ascensão A; Magalhães J; Martins MJ
Life Sci; 2015 Feb; 123():51-60. PubMed ID: 25534442
[TBL] [Abstract][Full Text] [Related]
16. Metabolic Stress Alters Antioxidant Systems, Suppresses the Adiponectin Receptor 1 and Induces Alzheimer's Like Pathology in Mice Brain.
Hahm JR; Jo MH; Ullah R; Kim MW; Kim MO
Cells; 2020 Jan; 9(1):. PubMed ID: 31963819
[TBL] [Abstract][Full Text] [Related]
17. Insulin resistance and neurodegeneration: roles of obesity, type 2 diabetes mellitus and non-alcoholic steatohepatitis.
de la Monte SM; Longato L; Tong M; Wands JR
Curr Opin Investig Drugs; 2009 Oct; 10(10):1049-60. PubMed ID: 19777393
[TBL] [Abstract][Full Text] [Related]
18. Sex-specific susceptibility to type 2 diabetes mellitus and preventive effect of linalyl acetate.
Shin YK; Hsieh YS; Han AY; Kwon S; Kang P; Seol GH
Life Sci; 2020 Nov; 260():118432. PubMed ID: 32941895
[TBL] [Abstract][Full Text] [Related]
19. Effects of constant light exposure on sphingolipidomics and progression of NASH in high-fat-fed rats.
Yue F; Xia K; Wei L; Xing L; Wu S; Shi Y; Lam SM; Shui G; Xiang X; Russell R; Zhang D
J Gastroenterol Hepatol; 2020 Nov; 35(11):1978-1989. PubMed ID: 32027419
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of diet- and genetically-induced brain insulin resistance on amyloid pathology in a mouse model of Alzheimer's disease.
Wakabayashi T; Yamaguchi K; Matsui K; Sano T; Kubota T; Hashimoto T; Mano A; Yamada K; Matsuo Y; Kubota N; Kadowaki T; Iwatsubo T
Mol Neurodegener; 2019 Apr; 14(1):15. PubMed ID: 30975165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
